Passage Bio Stock Investor Sentiment

PASG Stock  USD 0.62  0.11  21.57%   
Roughly 56% of all Passage Bio's stockholders are looking to take a long position. The analysis of the overall investor sentiment regarding Passage Bio suggests that some traders are interested. The current market sentiment, together with Passage Bio's historical and current headlines, can help investors time the market. In addition, many technical investors use Passage Bio stock news signals to limit their universe of possible portfolio assets.
  
over six months ago at news.google.com         
Ultragenyx Pharmaceutical Inc, Alector Inc, Passage Bio Inc, AVR - GuruFocus.com
Google News at Macroaxis
over six months ago at globenewswire.com         
Passage Bio to Present at Guggenheim Healthcare Talks 6th Annual Biotechnology Conference
Macroaxis News: globenewswire.com
over six months ago at news.google.com         
Exponential Stock Price Rise for Passage Bio Inc - BNN Breaking
Google News at Macroaxis
over six months ago at news.google.com         
Should You Buy Passage Bio Inc Stock on Monday - InvestorsObserver
Google News at Macroaxis
over six months ago at news.google.com         
7 Nano-Cap Stocks That Pack a Serious Punch for Their Weight - InvestorPlace
Google News at Macroaxis
over six months ago at bizjournals.com         
Lab Notes Parkinsons disease drug developer Enterin raises 5M
bizjournals News
over six months ago at news.google.com         
Is Passage Bio Inc Stock at the Top of the Biotechnology Industry - InvestorsObserver
Google News at Macroaxis
over six months ago at finance.yahoo.com         
Passage Bio Announces Promising Initial Data From Phase 12 Clinical Trial of PBFT02 in FTD-GRN and U...
Yahoo News
over six months ago at marketwatch.com         
Passage Bio Shares Surge 29 percent on Trial Data of Dementia Treatment PBFT02
marketwatch News
over six months ago at benzinga.com         
Neurology-Focused Passage Bio Reveals Initial Data From Dementia Study, Outlines Strategic Prioritie...
benzinga news
over six months ago at seekingalpha.com         
Passage Bio stock climbs 9 percent on dementia study, program update
seekingalpha News
over six months ago at benzinga.com         
Passage Bio Announces Promising Initial Data From Phase 12 Clinical Trial of PBFT02 in FTD-GRN and U...
benzinga news
over a year ago at thelincolnianonline.com         
FY2023 Earnings Forecast for Passage Bio, Inc. Issued By Chardan Capital
news
over a year ago at thelincolnianonline.com         
Passage Bio, Inc. to Post FY2023 Earnings of Per Share, Wedbush Forecasts
news
over a year ago at thelincolnianonline.com         
Passage Bio Price Target Cut to 5.00 by Analysts at Raymond James
news
Far too much social signal, news, headlines, and media speculation about Passage Bio that are available to investors today. That information is available publicly through Passage media outlets and privately through word of mouth or via Passage internal channels. However, regardless of the origin, that massive amount of Passage data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of Passage Bio news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of Passage Bio relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to Passage Bio's headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive Passage Bio alpha.

Passage Bio Performance against Dow Jones

 Price Growth (%)  
       Timeline  

Complementary Tools for Passage Stock analysis

When running Passage Bio's price analysis, check to measure Passage Bio's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Passage Bio is operating at the current time. Most of Passage Bio's value examination focuses on studying past and present price action to predict the probability of Passage Bio's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Passage Bio's price. Additionally, you may evaluate how the addition of Passage Bio to your portfolios can decrease your overall portfolio volatility.
Price Transformation
Use Price Transformation models to analyze the depth of different equity instruments across global markets
My Watchlist Analysis
Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like
FinTech Suite
Use AI to screen and filter profitable investment opportunities
Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
Aroon Oscillator
Analyze current equity momentum using Aroon Oscillator and other momentum ratios
Portfolio Analyzer
Portfolio analysis module that provides access to portfolio diagnostics and optimization engine
Alpha Finder
Use alpha and beta coefficients to find investment opportunities after accounting for the risk
Funds Screener
Find actively-traded funds from around the world traded on over 30 global exchanges
Cryptocurrency Center
Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency